4//SEC Filing
Beaudoin Margaret 4
Accession 0000899243-21-025074
CIK 0001840574other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:25 PM ET
Size
7.0 KB
Accession
0000899243-21-025074
Insider Transaction Report
Form 4
Beaudoin Margaret
Vice President, Finance
Transactions
- Purchase
Common Stock
2021-06-21$19.00/sh+1,000$19,000→ 1,000 total - Award
Stock Option (right to buy)
2021-06-17+10,799→ 10,799 totalExercise: $19.00Exp: 2031-06-16→ Common Stock (10,799 underlying)
Footnotes (1)
- [F1]The option was granted on June 17, 2021. 25% of the shares underlying the option will vest on June 1, 2022, and the remainder are scheduled to vest in equal monthly installments thereafter until June 1, 2025.
Documents
Issuer
Verve Therapeutics, Inc.
CIK 0001840574
Entity typeother
Related Parties
1- filerCIK 0001864505
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 6:25 PM ET
- Size
- 7.0 KB